Delivery Order SPE2DB20D1100-SPE2DB25FA6B4
Award Date
2/13/25
Potential Completion Date
2/14/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $11,218.95 and a completion date of June 18, 2024. This order is not designated as a set-aside contract. AmerisourceBergen holds a large IDC with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,568.42 contract is for the supply of 250 ml bottles of the medication Oxcarbazepine 300 mg/5 ml suspension. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The firm-fixed-price contract has a ceiling value of $1,324.26 and a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,135.08, is for the delivery of a specific pharmaceutical product, OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, with an ultimate completion date of May 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA....
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,481.62 firm fixed-price delivery order is for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Oxcarbazepine 300 mg/5 ml Suspension, 250 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,161.36, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 26, 2024. It is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,890.30, is for the supply of 4,558,996,119 Oxcarbazepine 300 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award, valued at $1,702.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. It is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 16, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp has significant experience providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,564.98 firm fixed-price delivery order is for the supply of the prescription medication oxcarbazepine 300 mg/5 ml suspension. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor, and the parent company is Cencora, Inc. (doing business as...